Biocompatibility of components of a female controlled drug delivery system

Journal of Biomedical Materials Research - Part A

Volumn 71, Issue 2, 2004, Pages 209-216

  Warrier, Bharat K ^a   Kostoryz, Elisabet ^a   Lee, Chi H ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Biocompatibility; Cytotoxicity; Estrogenicity; Ethylenediaminetetraacetic acid (EDTA); Vaginal

Indexed keywords

BINDING ENERGY; CELLS; DISEASES; DRUG DOSAGE; ELECTROPHORESIS; PROTEINS;

CYTOTOXICITY; LACTIC ACIDS; POLYMERASE CHAINS; SYNERGISTIC MICROBICIDE;

BIOCOMPATIBILITY;

DODECYL SULFATE SODIUM; EDETIC ACID; ELASTIN BINDING PROTEIN; ESTROGEN; LACTIC ACID; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DEVICE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; FEMALE; GEL ELECTROPHORESIS; HELA CELL; HORMONE DETERMINATION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; OVARY CELL CULTURE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEXUALLY TRANSMITTED DISEASE; VAGINA;

BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; EDETIC ACID; FEMALE; HUMANS; LACTIC ACID; NITRITES; RECEPTORS, CELL SURFACE; SODIUM DODECYL SULFATE;

EID: 5444266910     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30111     Document Type: Article

References (28)

1. Williams DF. Definitions in biomaterials. Vol. 4. Amsterdam: Elsevier; 1987.
2. Pizzoferrato A, Ciapetti G, Stea S, Cenni E, Arciola CR, Granchi D, Savarino L. Cell culture methods for testing biocompatibility. Clin Mater 1994;15:173-190.
3. Hanks CT, Wataha JC, Sun Z. In vitro models of biocompatibility: A review. Dent Mater 1996;12:186-193.
4. Singleton DW, Khan SA. Xenoestrogen exposure and mechanisms of endocrine disruption. Front Biosci 2003;8:S110-118.
5. Rockwell LC, Pillai S, Olson CE, Koos RD. Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 2002;67:1804-1810.
6. Tantini B, Pignatti C, Fattori M, Flamigni F, Stefanelli C, Giordano E, Menegazzi M, Clo C, Caldarera CM. NF-kappaB and ERK cooperate to stimulate DNA synthesis by inducing ornithine decarboxylase and nitric oxide synthase in cardiomyocytes treated with TNF and LPS. FEBS Lett 2002;13:75-79.
7. Al-Hijji J, Larsson B, Batra S. Nitric oxide synthase in the rabbit uterus and vagina: Hormonal regulation and functional significance. Biol Reprod 2000;62:1387-1392.
8. Hoyle CHV, Stones RW, Robson T, Whitley K, Burnstock G. Innervation of vasculature and microvasculature of human vagina by NOS and neuropeptide- containing nerves. J Anat 1996;188:633-644.
9. Wang Y, Lee CH. Characterization of a female controlled drug delivery system for microbicides. Contraception 2002;66:281-287.
10. Wyllie A, Donahue V, Fischer B, Hill D, Keesey J, Manzow S. Apoptosis and cell proliferation. 2nd ed. Germany: Boehringer Mannheim; 1998.
11. Kirkpatrick CJ, Bittinger F, Wagner M, Kohler H, van Kooten TG, Klein CL, Otto M. Current trends in biocompatibility testing. Proc Inst Mech Eng [H] 1998;212:75-84.
12. Varma H, Conrad SE. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling. Cancer Res 2002;15: 3985-3991.
13. Zacharewski T. In vitro bioassays for assessing estrogenic substances. Environ Sci Technol 1997;31:613-623.
14. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, De Clercq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 1988;20:309-332.
15. Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993;303:474-482.
16. Wiese TE, Kral LG, Dennis KE, Butler WB, Brooks. SC Optimization of estrogen growth response in MCF-7 cells. In Vitro Cell Dev Biol 1992;28A:595-602.
17. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983;64:313-320.
18. Griess P. Bermerkungen Zu der abhandlung der H.H. Weselsky und Benedikt, "Ueber einige azoverbindungen." Chem Ber 1879;12:426.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;15:680-685.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
21. Morreau H, Galjart NJ, Gillemans N, Willemsen R, van der Horst GTJ, d'Azzo A. Alternative splicing of β-galactosidase mRNA generates the classical lysosomal enzyme and a β-galactosidase-related protein. J Biol Chem 1989;264:20655-20663.
22. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF. Characterization of a human ovarian carcinoma cell line (NIH: Ovcar-3) with androgen and estrogen receptors. Cancer Res 1983;43:5379-5389.
23. Oda T, Tanaka M, Sasaki T. Cytotoxicity of synthetic estrogen and related compounds in various tumor-derived cells. Biol Pharm Bull 2001;24:1142-1144.
24. Fujimoto N, Tajima S, Ishibashi A. Elastin peptides induce migration and terminal differentiation of cultured keratinocytes via 67 kDa elastin receptor in vitro: 67 kDa elastin receptor is expressed in the keratinocytes eliminating elastic materials in elastosis perforans serpiginosa. J Invest Dermatol 2000; 115:633-639.
25. Debbasch C, De La Salle SB, Brignole F, Rat P, Warnet J-M, Baudouin C. Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells. Invest Ophthalmol Vis Sci 2002;43:3409-3415.
26. Devine PJ, Sipes IG, Skinner MK, Hoyer PB. Characterization of a rat in vitro ovarian culture system to study the ovarian toxicant 4-vinylcyclohexene diepoxide. Toxicol Appl 2002;184: 107-115.
27. Majumdar SK, Valdellon JA, Brown KA. In vitro investigations on the toxicity and cell death induced by tamoxifen on two non-breast cancer cell types. J Biomed Biotechnol 2001;1:99-107.
28. Choe ES, Warrier B, Chun JS, Park JC, Lee CH. EDTA-induced activation of Ca-regulated proteins in the vaginal mucosa. J Biomed Mater Res 2004;68A:159-167.